ARHGAP39 Antibodies

Santa Cruz Biotechnology features a diverse variety of ARHGAP39 monoclonal antibodies for research focused on understanding ARHGAP39 protein function. ARHGAP39 monoclonal antibodies are compatible with multiple experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).ARHGAP39, a member of the Rho GTPase-activating protein family, plays a crucial role in regulating cellular signaling pathways by inactivating Rho GTPases. This regulation is vital for processes such as cell migration, adhesion, and cytoskeletal dynamics, making ARHGAP39 an important player in various physiological and pathological conditions, including cancer progression and immune response. Understanding ARHGAP39 function can provide insights into its potential as a therapeutic target. ARHGAP39 monoclonal antibodies enable precise detection and analysis of expression patterns across different tissue types. Researchers can examine ARHGAP39 localization within cellular compartments and investigate its interactions with other molecules. Advanced imaging techniques combined with ARHGAP39 monoclonal antibodies reveal detailed protein distribution patterns. Santa Cruz Biotechnology monoclonal antibodies for ARHGAP39 support researchers worldwide in advancing scientific knowledge and developing potential therapeutic strategies.